Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fusen Pharmaceutical is a leading Chinese pharmaceutical group specializing in the development, manufacturing, and distribution of Traditional Chinese Medicine (TCM) and Western pharmaceutical products. The company is recognized as the largest manufacturer of Shuanghuanglian-based treatments in China, which are essential for managing symptoms of the common cold and influenza. Beyond its core respiratory portfolio, Fusen offers a diverse range of medicines for cardiovascular, gastrointestinal, and metabolic conditions. Headquartered in Henan Province and listed on the Hong Kong Stock Exchange, the company maintains a strategic presence in Macau through its subsidiary, Fusen Pharmaceutical (Macau) Limited, to support international business development and research initiatives. Fusen operates advanced GMP-certified production facilities and leverages an extensive sales network to serve both the over-the-counter and prescription drug markets across China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fusen Macau.